Meganerv Injection contains Methylcobalamin 500 mcg, an active form of vitamin B12 essential for neurological function and hematopoiesis. This injectable formulation is primarily indicated for the treatment of vitamin B12 deficiency, which may present as peripheral neuropathy, megaloblastic anemia, or other neurological disorders. Methylcobalamin plays a critical role in the synthesis of myelin, thereby supporting nerve regeneration and repair. Meganerv Injection is commonly used in clinical settings to manage conditions such as diabetic neuropathy, alcoholic neuropathy, and other neuropathic pain syndromes. It also aids in the treatment of pernicious anemia and other vitamin B12 deficiency-related disorders. The administration of Meganerv Injection ensures rapid bioavailability and effective correction of deficiency states, particularly in patients with malabsorption or increased metabolic demands. Dosage and duration of therapy should be determined by a healthcare professional based on the severity of deficiency and clinical response. Common adverse effects are rare but may include mild injection site reactions. Meganerv Injection should be used with caution in patients with hypersensitivity to cobalamin or any component of the formulation. Regular monitoring of clinical and hematological parameters is recommended during therapy to assess efficacy and safety.